Table 1.
To treat relapsed disease after stem-cell transplantation (SCT) |
Prophylactic DLI to prevent relapse and viral reactivation: |
T-cell-depleted grafts |
Non-myeloablative SCT |
Advanced disease stage |
Induce full donor chimerism |
Enhance immune reconstitution |
Treat viral infection after SCT |
Treat post-transplant lymphoproliferative disorder (PTLD) |